Back to search

Terminal complement complexes and C1/C1 inhibitor complexes in autoimmune thyroid disease.

Data up to Jan 2025

Published1989
Citations47
References25

Total Citations Per Year

Abstract

References (25)

Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

1984 • 3,268 citations

C-REACTIVE PROTEIN FIFTY YEARS ON

1981 • 690 citations

Purification of the human thyroid peroxidase and its identification as the microsomal antigen involved in autoimmune thyroid diseases

1985 • 364 citations

Autoimmune Thyroid Disease: Developments in Our Understanding

1984 • 344 citations

Immune Mechanisms In Graves' Disease

1985 • 217 citations

Monoclonal Antibodies Recognizing a Neoantigen of Poly(C9) Detect the Human Terminal Complement Complex in Tissue and Plasma

1985 • 200 citations

Hypothyroidism as a Late Sequela in Patients with Graves' Disease Treated with Antithyroid Agents

1979 • 172 citations

Presence of the organ-specific 'microsomal' autoantigen on the surface of human thyroid cells in culture: its involvement in complement-mediated cytotoxicity.

1981 • 170 citations

EVIDENCE FOR AN EFFECT OF ANTITHYROID DRUGS ON THE NATURAL HISTORY OF GRAVES' DISEASE

1984 • 139 citations

The recovery of human polymorphonuclear leucocytes from sublytic complement attack is mediated by changes in intracellular free calcium

1985 • 133 citations

Isolation of a complementary DNA clone for thyroid microsomal antigen. Homology with the gene for thyroid peroxidase.

1987 • 82 citations

Measurement of terminal complement complexes in rheumatoid arthritis.

1988 • 81 citations

Immune complex deposits in Graves' disease and Hashimoto's thyroiditis

1977 • 74 citations

Immunoglobulins (E, M, G) and Complement in the Connective Tissues of the Thyroid in Graves's Disease

1972 • 74 citations

Methods to detect and quantitate complement activation

1983 • 68 citations

Humoral immune killing of nucleated cells: mechanisms of complement-mediated attack and target cell defense.

1981 • 67 citations

Enzyme-linked immunoassay of monoclonal and serum microsomal autoantibodies

1984 • 45 citations

C1 inactivator-C1s complexes in inflammatory joint disease.

1983 • 29 citations

In vivo and in vitro evidence of cell recovery from complement attack in rheumatoid synovium.

1988 • 29 citations

Complement activation occurs through both classical and alternative pathways prior to onset and resolution of adult respiratory distress syndrome

1988 • 28 citations

Complement Components, C1 Activation and Disease Activity in SLE

1983 • 19 citations

Complement activation, circulating C1q binding substances and inflammatory activity in rheumatoid arthritis: relations and changes on suppression of inflammation.

1980 • 19 citations

Quantiation of (C1INH)2 C1r-C1s complexes in glomerulonephritis as an indicator of C1 activation

1987 • 14 citations

COMPLEMENT COMPONENT C9 IN GRAVES' DISEASE

1986 • 12 citations

Immune complex deposits in thyroid glands of patients with Graves' disease

1981 • 11 citations

Cited By (0)

Loading...
Terminal complement complexes and C1/C1 inhibitor complexes in autoimmune thyroid disease. (1989) – PubMed | Metascience Observatory Explorer